We typically think of personalized medicine as involving genomics, but it can utilize any patient specific biomarker. Depression treatment leads to a lot of medical expense. Pharmaceuticals are a primary treatment modality but often the first drug prescribed does not work, which can lead to patients abandoning treatment. (UCLA Release) Researchers at UCLA have now utilized a biomarker which may accelerate identification of drugs which are or aren’t likely to work for a specific patient. The technique involves using EEGs to study brain waves. A pattern of changes from a baseline EEG before treatment and one taken a week after drug use begins can predict the likelihood that the drug will work. While the test obviously involves some expense, it can avoid continued use of a drug which is not providing benefits and associated medical visits. It may also provide quicker improvement in a patient’s condition, which would allow better work and personal life functioning.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Best Buy is another large corporation trying to make a bet on health care, in this case largely by providing remote patient monitoring services. The company made yet another significant...
October 13, 2021
Just so men don’t feel left out, a company called Numan has raised $40 million for an app, yada, yada, yada, helping men with ED and other health issues. Also...
October 11, 2021
Money streams in to Flo, which sells an app for women to track menstrual cycles, etc. Investors hope they won’t be left up a creek. $100 million in financing that...
October 11, 2021
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace